 Patricia Heyn
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Equity | 9 | 2025 | 133 | 3.740 |
Why?
| | Cognitive Dysfunction | 9 | 2025 | 468 | 2.680 |
Why?
| | Cerebral Palsy | 6 | 2022 | 138 | 1.820 |
Why?
| | Terminology as Topic | 3 | 2025 | 259 | 1.730 |
Why?
| | Meta-Analysis as Topic | 3 | 2025 | 173 | 1.520 |
Why?
| | Cognition Disorders | 7 | 2016 | 544 | 1.520 |
Why?
| | Exercise | 8 | 2025 | 2205 | 1.260 |
Why?
| | Alzheimer Disease | 6 | 2024 | 630 | 1.210 |
Why?
| | Racism | 4 | 2025 | 147 | 1.140 |
Why?
| | Self-Help Devices | 3 | 2014 | 24 | 1.030 |
Why?
| | Exercise Therapy | 4 | 2025 | 475 | 1.000 |
Why?
| | Activities of Daily Living | 4 | 2021 | 444 | 0.940 |
Why?
| | Physical Therapy Modalities | 2 | 2020 | 337 | 0.860 |
Why?
| | Geriatrics | 5 | 2025 | 95 | 0.850 |
Why?
| | Cognition | 6 | 2025 | 1271 | 0.820 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 2 | 2026 | 36 | 0.800 |
Why?
| | Integrative Medicine | 2 | 2022 | 17 | 0.790 |
Why?
| | Aging | 6 | 2026 | 1973 | 0.780 |
Why?
| | Dementia | 6 | 2023 | 328 | 0.780 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2021 | 154 | 0.770 |
Why?
| | Video Games | 2 | 2021 | 30 | 0.770 |
Why?
| | Brain Injuries, Traumatic | 4 | 2026 | 453 | 0.750 |
Why?
| | Language | 1 | 2026 | 324 | 0.740 |
Why?
| | Parkinson Disease | 3 | 2024 | 601 | 0.710 |
Why?
| | Social Determinants of Health | 3 | 2024 | 309 | 0.700 |
Why?
| | Elder Nutritional Physiological Phenomena | 1 | 2021 | 1 | 0.690 |
Why?
| | Intellectual Disability | 1 | 2023 | 179 | 0.690 |
Why?
| | Humans | 73 | 2026 | 145783 | 0.680 |
Why?
| | Nutrition Therapy | 1 | 2021 | 37 | 0.660 |
Why?
| | Virtual Reality | 1 | 2022 | 82 | 0.660 |
Why?
| | Artificial Intelligence | 1 | 2026 | 381 | 0.660 |
Why?
| | Complementary Therapies | 2 | 2020 | 96 | 0.650 |
Why?
| | Developmental Disabilities | 1 | 2023 | 281 | 0.630 |
Why?
| | Internet | 1 | 2025 | 693 | 0.630 |
Why?
| | Accidental Falls | 2 | 2021 | 230 | 0.630 |
Why?
| | Home Care Services | 1 | 2023 | 284 | 0.590 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2019 | 57 | 0.570 |
Why?
| | Review Literature as Topic | 1 | 2019 | 52 | 0.570 |
Why?
| | Dwarfism | 1 | 2018 | 14 | 0.570 |
Why?
| | Polycomb-Group Proteins | 1 | 2018 | 36 | 0.570 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 35 | 0.560 |
Why?
| | DNA Methylation | 2 | 2026 | 690 | 0.560 |
Why?
| | Editorial Policies | 1 | 2019 | 45 | 0.550 |
Why?
| | Motor Skills | 1 | 2019 | 104 | 0.530 |
Why?
| | Microcephaly | 1 | 2018 | 104 | 0.530 |
Why?
| | Brain Diseases | 1 | 2019 | 155 | 0.520 |
Why?
| | Coiled Bodies | 1 | 2016 | 8 | 0.500 |
Why?
| | Cell Nucleolus | 1 | 2016 | 20 | 0.500 |
Why?
| | Femur Head Necrosis | 1 | 2016 | 15 | 0.480 |
Why?
| | Aged | 19 | 2026 | 26217 | 0.470 |
Why?
| | Physical and Rehabilitation Medicine | 1 | 2016 | 30 | 0.470 |
Why?
| | Hip Dislocation, Congenital | 1 | 2016 | 41 | 0.460 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1582 | 0.440 |
Why?
| | Walking | 2 | 2022 | 545 | 0.440 |
Why?
| | Metabolic Syndrome | 1 | 2019 | 361 | 0.430 |
Why?
| | Blood Pressure | 2 | 2021 | 1782 | 0.430 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 303 | 0.430 |
Why?
| | Histones | 2 | 2018 | 666 | 0.430 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 143 | 0.430 |
Why?
| | Transcriptional Activation | 1 | 2016 | 372 | 0.420 |
Why?
| | Diet | 2 | 2020 | 1278 | 0.420 |
Why?
| | Hip Joint | 1 | 2016 | 173 | 0.420 |
Why?
| | Pain Management | 1 | 2018 | 411 | 0.420 |
Why?
| | Chronic Pain | 1 | 2018 | 292 | 0.390 |
Why?
| | Life Style | 1 | 2016 | 486 | 0.390 |
Why?
| | Orthopedic Procedures | 1 | 2016 | 244 | 0.390 |
Why?
| | Caregivers | 2 | 2023 | 1074 | 0.360 |
Why?
| | Minority Groups | 2 | 2025 | 285 | 0.360 |
Why?
| | Zebrafish | 1 | 2016 | 532 | 0.350 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2025 | 1752 | 0.350 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1197 | 0.350 |
Why?
| | Gene Library | 1 | 2012 | 122 | 0.340 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 719 | 0.340 |
Why?
| | Mobile Applications | 1 | 2014 | 199 | 0.330 |
Why?
| | Brain | 6 | 2024 | 2969 | 0.330 |
Why?
| | Scoliosis | 2 | 2024 | 221 | 0.310 |
Why?
| | Reading | 1 | 2010 | 135 | 0.290 |
Why?
| | Cardiovascular Diseases | 2 | 2019 | 2191 | 0.290 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 534 | 0.270 |
Why?
| | Stress, Psychological | 1 | 2017 | 1151 | 0.270 |
Why?
| | Mental Health | 3 | 2023 | 796 | 0.270 |
Why?
| | Employment | 1 | 2010 | 184 | 0.260 |
Why?
| | Biomedical Research | 2 | 2025 | 719 | 0.250 |
Why?
| | Physical Endurance | 1 | 2008 | 279 | 0.240 |
Why?
| | United States | 9 | 2025 | 16126 | 0.240 |
Why?
| | Progeria | 1 | 2026 | 6 | 0.240 |
Why?
| | Fatigue | 4 | 2023 | 366 | 0.230 |
Why?
| | Resistance Training | 1 | 2008 | 186 | 0.220 |
Why?
| | DNA | 1 | 2012 | 1437 | 0.220 |
Why?
| | Aged, 80 and over | 6 | 2021 | 8347 | 0.210 |
Why?
| | Male | 16 | 2025 | 73010 | 0.210 |
Why?
| | Female | 17 | 2026 | 79045 | 0.210 |
Why?
| | Health Status Disparities | 2 | 2024 | 321 | 0.200 |
Why?
| | Oral Health | 1 | 2025 | 139 | 0.190 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 29 | 0.190 |
Why?
| | Patient Care Team | 2 | 2020 | 697 | 0.190 |
Why?
| | Research Personnel | 1 | 2025 | 185 | 0.190 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 148 | 0.190 |
Why?
| | Attention | 1 | 2026 | 463 | 0.180 |
Why?
| | Spinal Cord Injuries | 2 | 2017 | 235 | 0.180 |
Why?
| | Geriatricians | 1 | 2022 | 1 | 0.180 |
Why?
| | Acupuncture Therapy | 1 | 2022 | 21 | 0.180 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5925 | 0.170 |
Why?
| | Intracranial Pressure | 1 | 2022 | 65 | 0.170 |
Why?
| | Healthcare Disparities | 2 | 2025 | 736 | 0.170 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2026 | 430 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2024 | 190 | 0.170 |
Why?
| | Risk Assessment | 3 | 2022 | 3752 | 0.170 |
Why?
| | Young Adult | 5 | 2022 | 14254 | 0.160 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 1137 | 0.160 |
Why?
| | Hearing Disorders | 1 | 2020 | 10 | 0.160 |
Why?
| | Interviews as Topic | 1 | 2024 | 916 | 0.160 |
Why?
| | Shoes | 1 | 2020 | 19 | 0.160 |
Why?
| | Hydroxyethylrutoside | 1 | 2019 | 1 | 0.150 |
Why?
| | Rehabilitation Centers | 1 | 2020 | 39 | 0.150 |
Why?
| | Social Participation | 1 | 2020 | 29 | 0.150 |
Why?
| | Climate Change | 1 | 2022 | 177 | 0.150 |
Why?
| | Waist-Hip Ratio | 1 | 2019 | 37 | 0.140 |
Why?
| | Nutritive Value | 1 | 2019 | 41 | 0.140 |
Why?
| | DNA Modification Methylases | 1 | 2018 | 18 | 0.140 |
Why?
| | Cooking | 1 | 2019 | 57 | 0.140 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2018 | 92 | 0.140 |
Why?
| | Vision Disorders | 1 | 2020 | 179 | 0.140 |
Why?
| | Waist Circumference | 1 | 2019 | 143 | 0.140 |
Why?
| | Environment | 1 | 2020 | 293 | 0.140 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 64 | 0.130 |
Why?
| | Calcium Channel Blockers | 1 | 2019 | 166 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 261 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 96 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2968 | 0.130 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2016 | 2 | 0.130 |
Why?
| | HeLa Cells | 1 | 2018 | 632 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 268 | 0.130 |
Why?
| | Muscle Strength | 1 | 2020 | 332 | 0.120 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2016 | 23 | 0.120 |
Why?
| | Zygote | 1 | 2016 | 14 | 0.120 |
Why?
| | Risk Factors | 4 | 2023 | 10919 | 0.120 |
Why?
| | Health Personnel | 1 | 2023 | 757 | 0.120 |
Why?
| | RNA, Small Nuclear | 1 | 2016 | 40 | 0.120 |
Why?
| | DNA, Ribosomal | 1 | 2016 | 84 | 0.120 |
Why?
| | Spliceosomes | 1 | 2016 | 54 | 0.120 |
Why?
| | Brain-Computer Interfaces | 1 | 2016 | 12 | 0.120 |
Why?
| | Health Promotion | 1 | 2023 | 775 | 0.120 |
Why?
| | Quality of Life | 2 | 2021 | 3211 | 0.120 |
Why?
| | Age Factors | 2 | 2016 | 3346 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2016 | 130 | 0.120 |
Why?
| | Embryonic Development | 1 | 2016 | 125 | 0.120 |
Why?
| | Adolescent | 6 | 2024 | 22577 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2019 | 11794 | 0.110 |
Why?
| | Social Support | 1 | 2020 | 651 | 0.110 |
Why?
| | Pressure Ulcer | 1 | 2015 | 40 | 0.110 |
Why?
| | Pilot Projects | 1 | 2021 | 1898 | 0.110 |
Why?
| | RNA Splicing | 1 | 2016 | 284 | 0.110 |
Why?
| | Adult | 5 | 2022 | 40881 | 0.100 |
Why?
| | National Institute on Aging (U.S.) | 2 | 2025 | 4 | 0.100 |
Why?
| | Government Programs | 1 | 2014 | 27 | 0.100 |
Why?
| | Self Report | 1 | 2019 | 876 | 0.100 |
Why?
| | Sternoclavicular Joint | 1 | 2014 | 13 | 0.100 |
Why?
| | Engineering | 1 | 2014 | 31 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 6085 | 0.100 |
Why?
| | Joint Dislocations | 1 | 2014 | 60 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2191 | 0.100 |
Why?
| | Odds Ratio | 1 | 2016 | 1083 | 0.100 |
Why?
| | Anticoagulants | 1 | 2019 | 748 | 0.100 |
Why?
| | Brain Mapping | 1 | 2016 | 542 | 0.100 |
Why?
| | Prevalence | 2 | 2019 | 2875 | 0.090 |
Why?
| | Hypertension | 1 | 2021 | 1276 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4302 | 0.090 |
Why?
| | Sleep | 1 | 2020 | 889 | 0.090 |
Why?
| | Protein Binding | 1 | 2018 | 2240 | 0.090 |
Why?
| | Phenotype | 1 | 2021 | 3170 | 0.090 |
Why?
| | Time Factors | 2 | 2016 | 7134 | 0.090 |
Why?
| | Uracil | 1 | 2012 | 36 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 716 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1247 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2018 | 4151 | 0.080 |
Why?
| | Articulation Disorders | 1 | 2010 | 7 | 0.080 |
Why?
| | Research | 1 | 2014 | 431 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3551 | 0.080 |
Why?
| | Middle Aged | 4 | 2025 | 36309 | 0.080 |
Why?
| | Animals | 5 | 2026 | 38101 | 0.080 |
Why?
| | Models, Biological | 1 | 2016 | 1764 | 0.070 |
Why?
| | DNA Damage | 1 | 2012 | 437 | 0.070 |
Why?
| | Comprehension | 1 | 2010 | 187 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 428 | 0.070 |
Why?
| | Research Design | 2 | 2024 | 1139 | 0.070 |
Why?
| | Child Welfare | 1 | 2010 | 233 | 0.070 |
Why?
| | Disability Evaluation | 1 | 2010 | 311 | 0.070 |
Why?
| | Stroke | 1 | 2017 | 1271 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2913 | 0.060 |
Why?
| | Amantadine | 1 | 2026 | 8 | 0.060 |
Why?
| | Mice | 2 | 2026 | 18355 | 0.060 |
Why?
| | Primary Health Care | 1 | 2017 | 1737 | 0.060 |
Why?
| | Methylphenidate | 1 | 2026 | 49 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2933 | 0.060 |
Why?
| | Syndrome | 1 | 2026 | 381 | 0.060 |
Why?
| | Qualitative Research | 2 | 2024 | 1683 | 0.050 |
Why?
| | Mass Screening | 2 | 2022 | 1361 | 0.050 |
Why?
| | Logic | 1 | 2024 | 7 | 0.050 |
Why?
| | Child | 4 | 2024 | 22740 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2024 | 3634 | 0.050 |
Why?
| | India | 1 | 2025 | 213 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2026 | 185 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 378 | 0.050 |
Why?
| | Eye Diseases | 1 | 2005 | 97 | 0.050 |
Why?
| | Academies and Institutes | 1 | 2024 | 61 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 26 | 0.050 |
Why?
| | Thioredoxins | 1 | 2023 | 30 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 98 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2006 | 374 | 0.050 |
Why?
| | Rural Health | 1 | 2023 | 87 | 0.050 |
Why?
| | Head | 1 | 2024 | 123 | 0.050 |
Why?
| | Braces | 1 | 2022 | 25 | 0.050 |
Why?
| | Stem Cells | 1 | 2026 | 630 | 0.040 |
Why?
| | Walking Speed | 1 | 2022 | 53 | 0.040 |
Why?
| | Nursing Homes | 1 | 2003 | 174 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2026 | 693 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2022 | 214 | 0.040 |
Why?
| | Vision Tests | 1 | 2020 | 22 | 0.040 |
Why?
| | Affect | 1 | 2003 | 321 | 0.040 |
Why?
| | Vitamin D | 1 | 2024 | 404 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 611 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2022 | 222 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 354 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 523 | 0.040 |
Why?
| | Hearing | 1 | 2021 | 133 | 0.040 |
Why?
| | Hearing Tests | 1 | 2020 | 53 | 0.040 |
Why?
| | Gait | 1 | 2022 | 312 | 0.040 |
Why?
| | Health Behavior | 1 | 2004 | 791 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2010 | 6465 | 0.030 |
Why?
| | Rural Population | 1 | 2023 | 661 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 498 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2006 | 1244 | 0.030 |
Why?
| | Hypesthesia | 1 | 2017 | 21 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 2021 | 521 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1430 | 0.030 |
Why?
| | Muscle Weakness | 1 | 2017 | 92 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 470 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2181 | 0.030 |
Why?
| | Infant | 1 | 2010 | 10091 | 0.030 |
Why?
| | Symptom Assessment | 1 | 2017 | 136 | 0.030 |
Why?
| | Memory Disorders | 1 | 2017 | 197 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2017 | 251 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1736 | 0.030 |
Why?
| | Child, Preschool | 1 | 2010 | 11868 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2865 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 1074 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2017 | 217 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2024 | 2399 | 0.030 |
Why?
| | Mutation | 1 | 2026 | 4090 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2021 | 843 | 0.030 |
Why?
| | Manipulation, Orthopedic | 1 | 2014 | 8 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 54 | 0.030 |
Why?
| | Clavicle | 1 | 2014 | 38 | 0.020 |
Why?
| | Emotions | 1 | 2017 | 577 | 0.020 |
Why?
| | Fracture Fixation, Internal | 1 | 2014 | 214 | 0.020 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 80 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17330 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2977 | 0.010 |
Why?
| | Logistic Models | 1 | 2005 | 2139 | 0.010 |
Why?
|
|
Heyn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|